REGULUS THERAPEUTICS INC - COM NEW (RGLS)

CUSIP: 75915K200

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM NEW
Total 13F shares
6,330,314
Share change
-2,285,049
Total reported value
$4,312,113
Price per share
$0.68
Number of holders
29
Value change
-$1,059,157
Number of buys
14
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q2 2020

As of 30 Jun 2020, REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,330,314 shares. The largest 10 holders included NEA Management Company, LLC, Sarissa Capital Management LP, BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, and Tower Research Capital LLC (TRC). This page lists 29 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.